ITMCTR2000003621尚未招募1 期
Clinical study on the efficacy and safety of Yangxin Decoction in the treatment of angina pectoris (qi stagnation and blood stasis type) with anxiety and depression
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. According to the diagnostic criteria of Western medicine for coronary heart disease (one of the following criteria is met):
- •(1) he has received coronary revascularization therapy, including percutaneous coronary intervention and coronary artery bypass grafting;
- •(2) coronary angiography or coronary CT angiography results show that at least one coronary artery is narrow and the lumen stenosis is more than 50%;
- •(3) The patients were diagnosed as coronary heart disease and myocardial ischemia by dynamic or static or drug loading radionuclide myocardial scanning;
- •(4) having a clear history of myocardial infarction in the past. (Note: the results of one of the above four items provided by the tertiary hospital can be used as diagnostic evidence, and the copy is attached to the research medical record.)
- •2. The results showed that the patients met the diagnostic criteria of Western medicine for stable angina pectoris;
- •3. they met the syndrome differentiation criteria of qi deficiency and blood stasis in traditional Chinese medicine;
- •4. outpatients or inpatients aged between 18 and 70 years old (including boundary value);
- •5. patients of childbearing age agreed to use a medically acceptable non drug measure for contraception or abstinence within 3 months after the last medication;
- •6. Patients understand and follow the research process, which is sufficient to complete all the tests and examinations required by the protocol, communicate well with the researchers, participate in the trial voluntarily, and sign the informed consent form.
排除标准
- •1. patients with cardiac function grade 3-4 or pulmonary edema;
- •2. patients with severe primary brain and lung diseases and liver and kidney dysfunction;
- •3. patients with traditional Chinese medicine allergy;
- •4. patients with malignant diseases;
- •5. patients with severe inflammatory diseases;
- •6. patients with hemorrhagic diseases;
- •7. malignant arrhythmias;
- •8. acute coronary syndrome;
- •9. critical severe hypertension;
- •10. psychiatric patients;
- •11. pregnant or lactating women;
- •12. nearly 1 Participants in other clinical trials within months.
研究者
相似试验
尚未招募
1 期
Clinical Study of therapeutic effect of Yuyinyanggan decoction on patients of primary biliary cholangitis with 25-OH-D by LC-MS/MSITMCTR2000004008Shanghai Municipal Hospital of Traditional Chinese Medicine
尚未招募
4 期
Evaluation of the clinical efficacy of Guanxinning tablets in the treatment of patients with carotid atherosclerotic plaqueCarotid atherosclerotic plaque formationITMCTR2100005440Dongzhimen Hospital, Beijing University of Chinese Medicine
招募中
4 期
Clinical study on the efficacy and safety of Jieyuwan in the treatment of epidemic stress, anxiety and depression (stagnation of liver Qi syndrome)Anxiety and depressionITMCTR2100004368Dongfang Hospital Beijing University of Chinese Medicine
尚未招募
2 期
A clinical study of Yashtimadhukadi Taila in patients of Khalitya (Hair loss)CTRI/2023/08/056525State Ayurvedic College and Hospital Lucknow
尚未招募
不适用
Evaluation of clinical efficacy and mechanism of Yunv Decoction in treating type 2 diabetes mellitus with syndrome of yin deficiency due to intense heatdiabetes mellitusITMCTR2200005821Guang'anmen Hospital of China Academy of Chinese Medical Sciences